Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1ALAVERT

02 1ALPRAZOLAM

03 1ARICEPT ODT

04 1ARIPIPRAZOLE

05 2CARBIDOPA AND LEVODOPA

06 1CHILDRENS ALLEGRA ALLERGY

07 1CHILDRENS ALLEGRA HIVES

08 2CLONAZEPAM

09 1CLOZAPINE

10 1DONEPEZIL HYDROCHLORIDE

11 1FAZACLO ODT

12 1LAMOTRIGINE

13 1METOCLOPRAMIDE HYDROCHLORIDE

14 4MIRTAZAPINE

15 8OLANZAPINE

16 6ONDANSETRON

17 1PREDNISOLONE SODIUM PHOSPHATE

18 1REMERON SOLTAB

19 8RISPERIDONE

20 4RIZATRIPTAN BENZOATE

21 1STAXYN

22 3ZOLMITRIPTAN

23 1ZOMIG-ZMT

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

VARDENAFIL HYDROCHLORIDE

Drug : STAXYN

Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

Application Number : 200179

Country : US

Patented : Yes

Company Banner

02

arrow
PEGS Boston Summit
Not Confirmed
arrow
PEGS Boston Summit
Not Confirmed

ONDANSETRON

Drug : ONDANSETRON

Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

Application Number : 78152

Country : US

Patented : No

blank

03

SCIEGEN PHARMS
arrow
PEGS Boston Summit
Not Confirmed
SCIEGEN PHARMS
Country
arrow
PEGS Boston Summit
Not Confirmed

LAMOTRIGINE

Drug : LAMOTRIGINE

Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

Application Number : 206382

Country : US

Patented : No

blank

04

PHARMOBEDIENT
arrow
PEGS Boston Summit
Not Confirmed
PHARMOBEDIENT
Country
arrow
PEGS Boston Summit
Not Confirmed

OLANZAPINE

Drug : OLANZAPINE

Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

Application Number : 202285

Country : US

Patented : No

blank

05

PHARMOBEDIENT
arrow
PEGS Boston Summit
Not Confirmed
PHARMOBEDIENT
Country
arrow
PEGS Boston Summit
Not Confirmed

RIZATRIPTAN BENZOATE

Drug : RIZATRIPTAN BENZOATE

Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

Application Number : 78173

Country : US

Patented : No

blank

06

PHARMOBEDIENT
arrow
PEGS Boston Summit
Not Confirmed
PHARMOBEDIENT
Country
arrow
PEGS Boston Summit
Not Confirmed

ONDANSETRON

Drug : ONDANSETRON

Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

Application Number : 78139

Country : US

Patented : No

blank

07

PH HEALTH
arrow
PEGS Boston Summit
Not Confirmed
PH HEALTH
Country
arrow
PEGS Boston Summit
Not Confirmed

ALPRAZOLAM

Drug : ALPRAZOLAM

Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

Application Number : 78088

Country : US

Patented : No

blank

08

PH HEALTH
arrow
PEGS Boston Summit
Not Confirmed
PH HEALTH
Country
arrow
PEGS Boston Summit
Not Confirmed

RISPERIDONE

Drug : RISPERIDONE

Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

Application Number : 77494

Country : US

Patented : No

blank

09

PH HEALTH
arrow
PEGS Boston Summit
Not Confirmed
PH HEALTH
Country
arrow
PEGS Boston Summit
Not Confirmed

RISPERIDONE

Drug : RISPERIDONE

Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

Application Number : 77494

Country : US

Patented : No

blank

10

PH HEALTH
arrow
PEGS Boston Summit
Not Confirmed
PH HEALTH
Country
arrow
PEGS Boston Summit
Not Confirmed

CLONAZEPAM

Drug : CLONAZEPAM

Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

Application Number : 77171

Country : US

Patented : No

blank